Strategies for Global Launch of Medical Devices and Successful Clinical Trials
Wednesday, April 26, 2017
4:00 PM-5:30 PM
BIOMED Seminar
Title:
Thinking Globally, Acting Locally: Strategies for Global Launch of Medical Devices and Successful Clinical Trials
Speaker:
Seth J. Goldenberg, PhD
Director, Product Development Strategy
North American Science Associates (NAMSA)
Details:
The global healthcare and healthcare service market will maintain steady growth due in large part to an aging population that is living longer and to improved healthcare services in emerging markets that include China, Brazil, India, Japan, Israel, and South Korea, among others. It is interesting to note that countertrends seem to be developing in the medical device space. For example, hospital utilization of medical devices has slowed significantly, reimbursements continue to tighten, and there was a first-time global decrease (5%) in US pre-market approvals (PMAs) in 2012, a trend that is continuing. This talk will focus on what it takes to bring a medical device to market globally, with a particular emphasis on running successful clinical trials for high risk devices.
Biosketch:
Seth J. Goldenberg, PhD, is currently Director of Product Development Strategy with North American Science Associates (NAMSA), and previously was Director of Global Regulatory at NAMSA, as well as a former member of the US Food and Drug Administration (FDA). He holds a PhD in Pharmacology from the University of Washington and an MS from the School of Biomedical Engineering, Science and Health Systems at Drexel University. At NAMSA, Dr. Goldenberg works with over 1,000 NAMSA associates to develop global strategies for success taking into account regulatory, clinical, testing, and business considerations around the world. He has supported companies in direct interactions with the US FDA, several notified bodies, CFDA, ANVISA, MFDS, and many other global regulatory bodies.
Prior to joining NAMSA, Dr. Goldenberg founded a consulting company based in Shanghai supporting medical device market entry and local Chinese firms. Dr. Goldenberg understands not only what it takes to carry out scientific study, but also the importance of communicating it with the global scientific community to foster partnerships and collaboration, demonstrated by his strong publication record in such journals as Cell, Science, and Nature Cell Biology that have been cited over 1,200 times.
Contact Information
Ken Barbee
215-895-1335
barbee@drexel.edu